Tools
Tools
Dobson, R, Ghosh, AK, Ky, B, Marwick, T, Stout, M, Harkness, A, Steeds, R, Robinson, S, Oxborough, D, Adlam, D, Stanway, S, Rana, B, Ingram, T, Ring, L, Rosen, S, Plummer, C, Manisty, C, Harbinson, M, Sharma, V, Pearce, K , Lyon, AR and Augustine, DX (2021) BSE and BCOS Guideline for Transthoracic Echocardiographic Assessment of Adult Cancer Patients Receiving Anthracyclines and/or Trastuzumab. JACC: CardioOncology, 3 (1). pp. 1-16. ISSN 2666-0873
|
Text
BSE and BCOS Guideline for Transthoracic Echocardiographic Assessment of Adult Cancer Patients Receiving Anthracyclines ando.pdf - Published Version Available under License Creative Commons Attribution Non-commercial No Derivatives. Download (1MB) | Preview |
Abstract
The subspecialty of cardio-oncology aims to reduce cardiovascular morbidity and mortality in patients with cancer or following cancer treatment. Cancer therapy can lead to a variety of cardiovascular complications, including left ventricular systolic dysfunction, pericardial disease, and valvular heart disease. Echocardiography is a key diagnostic imaging tool in the diagnosis and surveillance for many of these complications. The baseline assessment and subsequent surveillance of patients undergoing treatment with anthracyclines and/or human epidermal growth factor receptor (HER) 2-positive targeted treatment (e.g., trastuzumab and pertuzumab) form a significant proportion of cardio-oncology patients undergoing echocardiography. This guideline from the British Society of Echocardiography and British Cardio-Oncology Society outlines a protocol for baseline and surveillance echocardiography of patients undergoing treatment with anthracyclines and/or trastuzumab. The methodology for acquisition of images and the advantages and disadvantages of techniques are discussed. Echocardiographic definitions for considering cancer therapeutics-related cardiac dysfunction are also presented.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | Science & Technology; Life Sciences & Biomedicine; Oncology; Cardiac & Cardiovascular Systems; Cardiovascular System & Cardiology; anthracycline; echocardiography; guidelines; HER2 therapy; imaging; VENTRICULAR EJECTION FRACTION; GLOBAL LONGITUDINAL STRAIN; EUROPEAN ASSOCIATION; AMERICAN SOCIETY; CARDIOVASCULAR TOXICITY; CLINICAL-PRACTICE; HEART-FAILURE; INTERVENDOR CONSISTENCY; CARDIAC DYSFUNCTION; TISSUE DOPPLER |
| Subjects: | R Medicine > R Medicine (General) R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer) R Medicine > RC Internal medicine > RC1200 Sports Medicine |
| Divisions: | Sport & Exercise Sciences |
| Publisher: | Elsevier |
| Related URLs: | |
| Date Deposited: | 20 Oct 2021 09:13 |
| Last Modified: | 20 Oct 2021 09:15 |
| DOI or ID number: | 10.1016/j.jaccao.2021.01.011 |
| URI: | https://researchonline.ljmu.ac.uk/id/eprint/15664 |
 |
View Item |